Omar Minshawi

Omar Minshawi has a diverse work experience spanning several companies and roles. Most recently, they have been working at SomaLogic as the Director of Strategic Accounts since October 2022. Prior to that, they were at Q² Solutions, where they held the positions of Director of Genomics Business Development from April 2021 to October 2022, and Associate Director of Genomics Business Development from August 2019 to April 2021.

Before joining Q² Solutions, Omar was the VP of Business Development and Marketing at In Vitro ADMET Laboratories (IVAL) from November 2018 to August 2019. Omar also worked as the Director of Business Development at HealthTell from April 2016 to November 2018, where they focused on the development of ImmunoSignaturing technology.

Omar's previous experience includes roles at HTG Molecular Diagnostics as the Director of Pharmaceutical Business Development CDx and DMPK from September 2014 to April 2016, and at ApoCell, Inc. as the Director of Business Development from April 2013 to September 2014. Omar began their career at Caliper Life Sciences as the Business Development Manager for the East Coast from August 2009 to April 2013, and at BD Biosciences as a Sales Consultant from October 2002 to July 2008.

In summary, Omar Minshawi has held various business development and strategic accounts roles in the life sciences industry, focusing on genomics, biomarker research, and pharmaceutical business development throughout their career.

Omar Minshawi attended DePauw University from 1995 to 1999, where they earned a Bachelor of Science (BS) degree in Biology and Economics. Prior to that, they completed their high school education from 1991 to 1995.